Central HER2 IHC and FISH analysis in a trastuzumab (Herceptin) phase II monotherapy study: assessment of test sensitivity and impact of chromosome 17 polysomy. | J Clin Pathol;61(1): 89-94, 2008 Jan. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Central HER2 IHC and FISH analysis in a trastuzumab (Herceptin) phase II monotherapy study: assessment of test sensitivity and impact of chromosome 17 polysomy.

Hofmann, M; Stoss, O; Gaiser, T; Kneitz, H; Heinmöller, P; Gutjahr, T; Kaufmann, M; Henkel, T; Rüschoff, J.

Affiliation

Hofmann M; Institute of Pathology and Biomedical Research, Klinikum Kassel GmbH, Kassel, Germany.

J Clin Pathol ; 61(1): 89-94, 2008 Jan.

Article in En | MEDLINE | ID: mdl-17412870

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Biomarkers, Tumor / Receptor, ErbB-2 / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Diagnostic_studies / Guideline Limits: Female / Humans Language: En Journal: J Clin Pathol Year: 2008 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Biomarkers, Tumor / Receptor, ErbB-2 / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Diagnostic_studies / Guideline Limits: Female / Humans Language: En Journal: J Clin Pathol Year: 2008 Document type: Article Affiliation country: Country of publication: